VEGFA and diabetic macular edema: In recent decades, multiple studies have evaluated the efficacy and safety of the intravitreal slow-release dexamethasone implant, often through comparisons with other intravitreal drugs used in the treatment of diabetic macular edema, such as anti-VEGF medications [12,13].